bte365官网

logo

Company Profile

Youcare Pharmaceutical Group, founded in 2001, headquartered in Beijing and listed in 2020 (Stock Code: 688658SH), is a large-scale conglomerate integrating the new drug R&D, pharmaceutical manufacture, distribution & sales as well as international business.


With “Products, Production capacity and Productive industry chain” as the core, Youcare raised its own pharmaceutical R&D institute in Beijing, and it built a series of preparation production bases in the center cities of Beijing, Guangzhou and Hefei, on the basis of the API production bases in Anhui and Henan province.


For now, there are over 200 drug products of multiple strengths in the whole group, covering cardio-cerebrovascular, gastrointestinal system, anti-infection, endocrinology anti-tumour and other therapeutic areas. In terms of manufacture and quality management, Youcare keeps promoting technical innovation and performs intelligent manufacture and green production, to align its quality system with the heading pharmaceutical manufacturer internationally.


Starting with a global perspective, Youcare takes initiative in exploring the market for pharmaceutical imports and exports and building business association with international pharmaceutical companies. Currently, Youcare have engaged with numerous steadfast, enduring, prominent business partners from Italy, France, Germany, Japan, Korea, India, Pakistan, Uzbekistan, Chile and more than 50 countries or regions.

R&D
FPP
API
Distribution And Sales
International Trade
en_icon01
R&D
FPP
API
Distribution And Sales
International Trade
Youcare Group Structure
Beijing Yolax Pharmaceutical Technology Co., LTD
20250226224013_2340_1874x1057
Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd (Youcare Pharmaceutical Group Research Centre)
20250226224119_0065_1728x979
Hangzhou Tianlong Pharmaceutical Co., Ltd.
20250226224143_4352_1920x1084
Youcare Group Structure
Youcare Pharmaceutical Group Co., Ltd (Beijing Preparation Production Base)
20250226224331_2233_1349x764
Guangzhou Youcare Biopharmaceutis Co., Ltd
20250226224359_4762_1919x1084
Anhui Youbo Biopharmaceutical Co., Ltd
20250226224429_3210_1780x1005
Youcare Group Structure
Henan Kangda Pharmaceutical Co., Ltd
20250226225115_9373
Youcare Pharmaceutical Group Anhui Natural Pharmaceutical Co., Ltd
20250226224516_0778
Anhui Youcare Kaiyue Pharmaceutical Co., Ltd
20250226225032_2917
Youcare Group Structure
Guangdong Youcare Pharmaceutical Co., LTD
Company-Profile_EN_bte365官网
Chongqing Youcare Kairui Pharmaceutical Co., LTD
Company-Profile_EN_bte365官网
Youcare Group Structure
Youcare International Trade Co., LTD
Company-Profile_EN_bte365官网
Zhuhai Special Economic Developing Zone Yuekang Medical Corporation LTD
Company-Profile_EN_bte365官网
R&D
20250226225403_0458_1920x1084

Technology platforms

Innovative drugs focusing on core indications such as cardiovascular, oncology, and infectious diseases

Innovative drugs focusing on nucleic acids, peptides, cell therapies,small molecule drugs, and Innovative TCMs.

Youcare Research Center Highlights

Achievements
2Second prize of National Science and Technology Progress Award
20first-class new drugs are under research
38in research and consistency evaluation projects
42provincial &ministerial level's science and technology projects, including 22 national level projects
233patents have been obtained, including 132 invention patents
Team
10More than 10 renowned academicians in China and abroad lead the R&D projects
500More than 500 of doctors & masters of R&D team from the Academy of Military Medical Sciences, Tsinghua University,University of Chinese Academy of Sciences, Peking Union Medical College.
Platform
Nucleic acid drug development platform covers target screening, validation, antigen design, evaluation, CMC pilot test, scale up, GMP production and quality control development stage
The laboratory has small nucleic acid drug pilot production line and mRNA vaccine pilot production line, which can synthesize hundredgram-gradenucleic acid drugs and samples
DDS&Tech
Cationic lipids with independent intellectual property rights, and related patents have been declared
Targeted delivery technologies, such as antibody conjugation, immunoglobulin conjugation, peptide conjugation and other biological conjugation technologies are under developing.
Achievements Team Platform DDS&Tech
en_03

Company Culture

  • en_04
    Values
    Fully 100% drug quality counts for all while 99% means nothing
  • 20250226225733_4966_1825x1283
    Vision
    Be a global provider of health products and services
  • 20250226225801_8628_1213x853
    Mission
    Creation of global Joy, care of human health

Events

2001
2002
2005
2007
2008
2009
2011
2012
2014
2015
2016
2017
2018
2020
2021
18 October - First plant landed in Beijing, along with the headquarters.?
13 September - First drug approval.
30 December - First GMP certification of Youcare’s plant.
Antibiotic products sales reaching CNY 160 million.
23 March - Founding of Guangzhou Youcare Biopharmaceutis Co., Ltd.
10 August - Founding of Youcare Pharmaceutical Group Anhui Natural Pharmaceutical Co., Ltd.
15 August - Firstling of export drugs got licensed in RUSSIA (Ceftriaxone sodium for injection, Cefoperazone sodium for injection).
Youcare’s output first hit CNY 1 billion.
Initiation of “Beijing Youcare Science & Innovation Pharmaceutical Technology Co.” on 29 April.
Named as one of the “Top 100 in China’s Pharmaceutical Industry”.
First time for Youcare’s production lines of tablets and capsules certified by EU-GMP on 10 July.
Henan Kangda pharmaceutical Co. set up as an API subsidiary on 9 July.
Launching of Youcare’s exclusive product, Extract of Ginkgo biloba leaves.
Omeprazole enteric-coated capsules exported to Germany.
On 26 March, Mr. Yu Weishi, as a representative of the business community, attended the Sino-France Business Forum and signed the cooperation paper on medicine.
Beijing engineering laboratory for the cephalosporins crystal forms founded in Youcare.
J-GMP certification of Youcare’s manufacturing site in Guangzhou city.
Beijing engineering research center for the cardio-cerebrovascular founded in Youcare.
Second prize of the National Scientific and Technological Advancement for omeprazole series developing in the industrialization and internationalization.
Upgrading of crystal-form lab of the cephalosporins as a national engineering lab.
Second prize of the National Scientific and Technological Advancement for crystal-form techniques of chemical drugs.
Granted as “National Exemplary Company for Quality”.
Establishment of Youcare’s drug research institute.
Nominated as“National Pioneer Company for Intelligent Manufacture” on 11 February.
“National Exemplary Manufacturing System for Green Factory Construction”.
24 December - Youcare boarded on the Shanghai Stock Exchange STAR Market.
29 December - Ailis® Aildenafil Citrate Tablets, a class-1.1 new drug for male with ED approved for marketing.
x
20201221105837_0072
官方微信
【网站地图】